AIM ImmunoTech Inc.

LSE:0A4Y Stock Report

Market Cap: US$4.5m

AIM ImmunoTech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

LSE:0A4Y Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
13 Jun 25BuyUS$824Thomas EquelsIndividual107US$7.70
12 Jun 25BuyUS$896Thomas EquelsIndividual103US$8.70
11 Apr 25BuyUS$5,000William MitchellIndividual1,968.51US$2.54
11 Apr 25BuyUS$50,000Thomas EquelsIndividual19,685.04US$2.54
11 Apr 25BuyUS$50,000Ted KellnerIndividual19,685.04US$2.54
04 Apr 25BuyUS$44Peter RodinoIndividual5US$8.70
04 Apr 25BuyUS$2,583Thomas EquelsIndividual410US$6.30
05 Mar 25BuyUS$6,730Thomas EquelsIndividual500US$13.46
04 Mar 25BuyUS$5,060Thomas EquelsIndividual440US$11.50
04 Mar 25BuyUS$10,000Thomas EquelsIndividual833.34US$12.00
19 Dec 24SellUS$884William MitchellIndividual45.8US$19.30
18 Dec 24BuyUS$4,682Thomas EquelsIndividual227.27US$20.60
02 Dec 24BuyUS$2,356Stewart AppelrouthIndividual111.12US$21.20

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0A4Y?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders106,0913.72%
Institutions140,7494.93%
General Public2,606,27491.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 347.9%.

Top Shareholders

Top 25 shareholders own 8.65% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
1.52%
DRW Holdings, LLC
43,291US$68.7k0%no data
1.36%
Thomas Equels
38,870US$61.7k-0.04%no data
1.3%
Ted Kellner
37,205US$59.0k-25.7%no data
1.17%
Armistice Capital LLC
33,497US$53.2k0%no data
1.01%
Sabby Management, LLC
28,855US$45.8k0%0.28%
0.61%
The Vanguard Group, Inc.
17,502US$27.8k-28.4%no data
0.6%
Todd Deutsch
17,161US$27.2k0%no data
0.57%
Geode Capital Management, LLC
16,186US$25.7k205%no data
0.18%
William Mitchell
5,218US$8.3k-0.06%no data
0.14%
Peter Rodino
4,011US$6.4k-0.17%no data
0.1%
Nancy Bryan
2,918US$4.6k-0.03%no data
0.03%
Morgan Stanley
863US$1.4k13.3%no data
0.022%
David Chemerow
641US$1.0k-0.16%no data
0.011%
UBS Asset Management AG
304US$482.7-74.3%no data
0.0046%
Nottingham Advisors Inc.
132US$209.60%no data
0.0018%
The PNC Financial Services Group, Inc.
50US$79.20%no data
0.0016%
Wayne Springate
47US$74.70%no data
0.00095%
Bank of America Corporation
27US$43.0440%no data
0.0007%
Paul Sweeney
20US$31.70%no data
0.00053%
Osaic Wealth, Inc.
15US$24.050%no data
0.00035%
Harbour Investments, Inc.
10US$15.80%no data
0.00035%
Hoey Investments, Inc.
10US$15.80%no data
0.00014%
Wells Fargo & Company
4US$6.30%no data
0.00007%
Steward Partners Investment Advisory, LLC
2US$3.20%no data
0.00004%
Farther Finance Advisors, LLC
1US$1.80%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/26 21:40
End of Day Share Price 2025/11/26 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

AIM ImmunoTech Inc. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC
Ling WangChardan Capital Markets, LLC